PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'State Key Laboratory of Membrane Biology, School of Medicine, Tsinghua University, Beijing, China.\', \'Seventh Medical Center, Chinese PLA General Hospital, Beijing, China.\', \'Beijing Tscell Biotech Ltd., Beijing, China.\', \'Center for Infectious Disease Research, School of Medicine, Tsinghua University, Beijing, China.\', \'Comprehensive AIDS Research Center, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing Advanced Innovation Center for Structural Biology, Department of Basic Medical Sciences, School of Medicine, Tsinghua University, Beijing, China.\', \'Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Electronic address: caiming918@hust.edu.cn.\', \'State Key Laboratory of Membrane Biology, School of Medicine, Tsinghua University, Beijing, China. Electronic address: zhijiec@tsinghua.edu.cn.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1873-5061(20)30367-610.1016/j.scr.2020.102066
?:doi
?:hasPublicationType
?:journal
  • Stem cell research
is ?:pmid of
?:pmid
?:pmid
  • 33242791
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.214
?:rankingScore_hIndex
  • 48
is ?:relation_isRelatedTo_publication of
?:title
  • A safety consideration of mesenchymal stem cell therapy on COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all